Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.
A Fond du Lac woman is suing Pfizer and others over a brain tumor, arguing it’s associated with Depo-Provera, a form of birth ...
A 34-year, named Adan (name changed), hailing from Ghana, South Africa adhering to Jehovah’s beliefs, presented with symptoms ...
They studied 36 FFPE samples from patients with meningioma—a common and benign brain tumor—and used a novel computational approach to integrate this data with nearly 1,300 publicly available ...
On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.
They wanted to help but there wasn’t really anything they could confidently do.” Her family researched other treatment ...
The Rotorua woman is going to the US this month for surgery and radiation, costing about $550,000. It was a “hard decision” ...
Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...
They studied 36 FFPE samples from patients with meningioma – a common and benign brain tumor – and used a novel computational approach to integrate this data with nearly 1,300 publicly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback